You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Baxter
Medtronic
McKesson
Harvard Business School

Last Updated: February 26, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 211455

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

NDA 211455 describes METHYLERGONOVINE MALEATE, which is a drug marketed by Am Regent, Breckenridge, Amneal Pharms, Granules Pharms, Novel Labs Inc, Teva Pharms Usa, and Tulex Pharms Inc, and is included in seven NDAs. It is available from fourteen suppliers. Additional details are available on the METHYLERGONOVINE MALEATE profile page.

The generic ingredient in METHYLERGONOVINE MALEATE is methylergonovine maleate. There is one drug master file entry for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the methylergonovine maleate profile page.
Summary for 211455
Tradename:METHYLERGONOVINE MALEATE
Applicant:Teva Pharms Usa
Ingredient:methylergonovine maleate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 211455
Medical Subject Heading (MeSH) Categories for 211455
Suppliers and Packaging for NDA: 211455
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHYLERGONOVINE MALEATE methylergonovine maleate TABLET;ORAL 211455 ANDA Teva Pharmaceuticals USA, Inc. 0093-3655 0093-3655-22 12 TABLET in 1 BOTTLE (0093-3655-22)
METHYLERGONOVINE MALEATE methylergonovine maleate TABLET;ORAL 211455 ANDA Teva Pharmaceuticals USA, Inc. 0093-3655 0093-3655-28 28 TABLET in 1 BOTTLE (0093-3655-28)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.2MG
Approval Date:Mar 20, 2019TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Medtronic
Dow
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.